The main goal of this funding opportunity is to enhance genetic risk assessment for type 1 diabetes (T1D), with a focus on improving prediction across ancestral backgrounds and advancing genetic risk scores (GRS) to support future use in real-world screening, and the detection and prevention of T1D.
This Request for Applications (RFA) will award grants to non-profit and for-profit entities such as academic institutions and industry partners of up to $900,000.00 each and up to 3 years.
Breakthrough T1D